Merck shares jump after combination trial shows Keytruda extends lung cancer survival

Jan 17, 2018 , CNBC Health
Merck's blockbuster drug Keytruda in combination with two chemotherapy drugs was successful as a first line treatment for lung cancer.

Read the full story...

Trending healthcare news keywords at this moment

drugs fda cancer care patients women study drug dementia flu blood test heart trump's linked brain risk lung people world season good kids child stroke healthy tip vaccine cdc products disease state highlights epidemic children work medical healthcare home rite aid launches opioid finds low-carb low-fat albertsons -- breast diabetes